Literature DB >> 10832485

Prevalence of antibodies to West Nile fever, sandfly fever Sicilian, and sandfly fever Naples viruses in healthy adults in Israel.

D Cohen1, Y Zaide, E Karasenty, M Schwarz, J W LeDuc, R Slepon, T G Ksiazek, J Shemer, M S Green.   

Abstract

BACKGROUND: The arbovirus infections West Nile fever (WNF) and sandfly fever (SFF) are both endemic in the Middle East. Despite the fact that the mosquito and sandfly vectors of these viruses are still found in Israel, SFF has not been reported since 1948, whereas outbreaks of WNF occur periodically. It is suspected that some of the cases of nonspecific febrile illnesses in Israel may in fact be either WNF or SFF. AIM: To determine the extent of past arbovirus infections in subgroups of Israeli soldiers.
METHODS: Sera from random samples of three groups of healthy soldiers aged 18-20 (n=273), 21-30 (n=497), and 40-55 years (n=285) were examined for IgG and IgM antibodies to West Nile virus (WNV), sandfly fever Sicilian virus (SFSV), and sandfly fever Naples virus (SFNV), using an ELISA method.
RESULTS: The prevalence of antibodies increased with age for all three viruses examined, and ranged from 7.0%, 0, and 2.8%, for WNV, SFSV, AND SFNV, respectively, in soldiers aged 18-20 years, to 41.9%, 23.7%, and 30.8%, in those aged 40-55 years. The percentage of seropositives for IgG who were also IgM positive were 1.0%, 5.9%, and 3.4%, for WNV, SFSV, AND SFNV, respectively. 17.5% of the seropositives for WNV were also positive for SFSV, as compared with 5.7% among the WNV-seronegatives. Among the seropositives for WNV, 23.99% were positive for SFNV, compared with 9.1% of WNV seronegatives. 48.2% of seropositives for SFSV were positive for SFNV, as compared with 8.4% for SFSV-seronegatives. In the age agroup 40-55 years, there were significantly higher prevalence rates in those born in Israel compared with those born abroad.
CONCLUSIONS: There is still significant exposure to WNV, SFSV, and SFNV in Israel. Arborviruses are probably responsible for many cases of non-specific febrile illness in this region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10832485

Source DB:  PubMed          Journal:  Public Health Rev        ISSN: 0301-0422


  14 in total

1.  Post-epidemic serosurvey of West Nile fever in Israel.

Authors:  M Y Chowers; M S Green; H Bin; M Weinberger; F Schlaeffer; S Pitlik; J Bishara; Z Kaufman; R Dichtiar; E Mendelson; S Segev
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

2.  Sensitivity and Kinetics of an NS1-Based Zika Virus Enzyme-Linked Immunosorbent Assay in Zika Virus-Infected Travelers from Israel, the Czech Republic, Italy, Belgium, Germany, and Chile.

Authors:  Yaniv Lustig; Hana Zelena; Giulietta Venturi; Marjan Van Esbroeck; Camilla Rothe; Cecilia Perret; Ravit Koren; Shiri Katz-Likvornik; Ella Mendelson; Eli Schwartz
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

3.  Serological studies of West Nile virus in a liver transplant population.

Authors:  L E Nicolle; A Gutkin; G Smart; M Dawood; M Drebot; P Van Caeseele; A Giulivi; Gy Minuk
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

4.  Toscana virus epidemiology: from Italy to beyond.

Authors:  Maria G Cusi; Gianni G Savellini; Giacomo Zanelli
Journal:  Open Virol J       Date:  2010-04-22

5.  Molecular and serological evidence for the presence of novel phleboviruses in sandflies from northern algeria.

Authors:  Grégory Moureau; Laurence Bichaud; Nicolas Salez; Laetitia Ninove; Boussad Hamrioui; Smail Belazzoug; Xavier de Lamballerie; Arezki Izri; Rémi N Charrel
Journal:  Open Virol J       Date:  2010-04-22

6.  Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel.

Authors:  M Hindiyeh; L M Shulman; E Mendelson; L Weiss; Z Grossman; H Bin
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

7.  Clinical characteristics of the West Nile fever outbreak, Israel, 2000.

Authors:  M Y Chowers; R Lang; F Nassar; D Ben-David; M Giladi; E Rubinshtein; A Itzhaki; J Mishal; Y Siegman-Igra; R Kitzes; N Pick; Z Landau; D Wolf; H Bin; E Mendelson; S D Pitlik; M Weinberger
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

8.  West Nile fever outbreak, Israel, 2000: epidemiologic aspects.

Authors:  M Weinberger; S D Pitlik; D Gandacu; R Lang; F Nassar; D Ben David; E Rubinstein; A Izthaki; J Mishal; R Kitzes; Y Siegman-Igra; M Giladi; N Pick; E Mendelson; H Bin; T Shohat
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

9.  West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey.

Authors:  Benoit Durand; Véronique Chevalier; Régis Pouillot; Jacques Labie; Ingrid Marendat; Bernadette Murgue; Hervé Zeller; Stéphan Zientara
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

10.  Sandfly fever Sicilian virus, Algeria.

Authors:  Arezki Izri; Sarah Temmam; Grégory Moureau; Boussad Hamrioui; Xavier de Lamballerie; Rémi N Charrel
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.